Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.39 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28104497 | 0.96 | TSHR (0.46) | TSHRCYP2C9HTTLMNAACHE | |
| SCHEMBL14363845 | 0.84 | ACHE (0.48) | TSHRCYP2C9HTTLMNAACHE | |
| SCHEMBL16253390 | 0.84 | GAA (0.40) | TSHRCYP2C9HTTLMNAACHE | |
| SCHEMBL2089381 | 0.83 | ACHE (0.41) | TSHRLMNAACHESMN1; SMN2TDP1 | |
| SCHEMBL23457804 | 0.79 | ACHE (0.65) | TSHRCYP2C9LMNAACHESMN1; SMN2 | |
| SCHEMBL12374357 | 0.79 | TRPA1 (0.46) | HTTLMNAACHESMN1; SMN2TDP1 | |
| SCHEMBL16574317 | 0.79 | MAOB (0.41) | TSHRCYP2C9HTTLMNAACHE | |
| SCHEMBL16022012 | 0.79 | CASP1 (0.47) | TSHRHTTLMNASMN1; SMN2GAA | |
| SCHEMBL28342821 | 0.79 | CYP3A4 (0.42) | TSHRLMNATDP1HTR2BALDH1A1 | |
| SCHEMBL12121021 | 0.79 | ACHE (0.43) | CYP2C9HTTLMNAACHESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212163-A1 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| CN-106167473-B | 1,4,2- dioxy nitrogen azole compounds and its synthetic method | 南开大学 | 2019-04-05 | — | — | CN | disclosed |
| US-9856346-B2 | Lignin-based biomass epoxy resin, method for manufacturing the same, and compositions including the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2018-01-02 | — | — | US | disclosed |
| US-9723769-B2 | Liquid crystal display device, alignment film, and methods for manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9704612-B2 | Composition of silver-conjugated compound composite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-20160102170-A1 | LIGNIN-BASED BIOMASS EPOXY RESIN, METHOD FOR MANUFACTURING THE SAME, AND COMPOSITIONS INCLUDING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-04-14 | — | — | US | disclosed |
| US-9081237-B2 | Pixel electrode panel, a liquid crystal display panel assembly and methods for manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-07-14 | — | — | US | disclosed |
| US-9057917-B2 | Pixel electrode panel, a liquid crystal display panel assembly and methods for manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-06-16 | — | — | US | disclosed |
| US-20150163968-A1 | LIQUID CRYSTAL DISPLAY DEVICE, ALIGNMENT FILM, AND METHODS FOR MANUFACTURING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2015-06-11 | — | — | US | disclosed |
| US-9024022-B2 | Substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof | CIS BIO INTERNATIONAL (FR) | 2015-05-05 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| WO-2006035954-A1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-04-06 | — | — | WO | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-0972758-B1 | A process for producing phenolic compounds | MITSUBISHI GAS CHEMICAL CO (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1209145-A2 | Process for preparing an aryl formate and an aromatic carboxylic acid | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-6187964-B1 | FORMING AN ARYL FORMATE AND AROMATIC CARBOXYLIC ACID BY OXIDATION AN AROMATIC ALDEHYDE WITH OXYGEN, SEPARATION A CARBOXYLIC ACID, ARYL FORMATE, UNREACTED ALDEHYDE MIXTURE AND DECOMPOSITION OF FORMATE TO PHENOL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0972758-A2 | A process for producing phenolic compounds | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2000-01-19 | — | — | EP | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | TSHR 319/4885CYP2C9 2351/4885HTT 4644/4885 |
| US-20230212163-A1 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | EPHX2, CYP8B1, CYP4X1 | TSHR 1053/4885CYP2C9 131/4885HTT 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.